Roberto Bilotti has removed the piece from Galleria Nazionale d’Arte Moderna e Contemporanea in Rome, claiming it was being exhibited in “a dark corner” and was “not valued at all” ...

sentiment for Moderna plunged to ‘extremely bearish’ levels, hitting levels last seen in February 2024. Meanwhile, soaring message volume drove the ticker into the top three trending symbols ...

Violence against women For the weekly Donna Moderna, Toscani devised a campaign ... An image captured by the photographer as a symbol of alternative, out-of-the-box beauty.

Moderna is the only company in its peer group burning cash at an alarming rate. Click here to read more about MRNA stock and ...

Delving into the details, we found 51% of traders were bullish, while 25% showed bearish tendencies. Out of all the trades we ...

Shares of vaccine maker Moderna fell Wednesday as Goldman Sachs lowered its rating after the biotech’s second cut to product ...

For the fourth time in five months, the Prescription Medicines Code of Practice Authority (PMCPA) has ruled that Moderna brought discredit on the pharma industry. Moderna received the latest ...

Moderna made a lot of money during the pandemic, but its post-pandemic prospects look bleak. Sales in 2025 could be down more than half from 2024 levels, according to Moderna's latest guidance ...

Moderna fell to a new 52-week low after some disappointing news. The short explanation is that demand for Moderna's COVID-19 vaccine has plunged since the end of the pandemic. Moderna still has ...

Moderna (NASDAQ:MRNA) shares plunged 20% premarket on Monday after the biotech firm cut its revenue guidance for 2025 on slow demand for its Covid and RSV vaccines. The company projects revenue in ...

In this article, we are going to take a look at where Moderna Inc. (NASDAQ:MRNA) stands against the other stocks. Ten companies kicked off this week’s trading with significant losses ...